Does IDARUBICIN Cause Second primary malignancy? 104 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 104 reports of Second primary malignancy have been filed in association with IDARUBICIN (Idamycin PFS). This represents 2.1% of all adverse event reports for IDARUBICIN.
104
Reports of Second primary malignancy with IDARUBICIN
2.1%
of all IDARUBICIN reports
43
Deaths
7
Hospitalizations
How Dangerous Is Second primary malignancy From IDARUBICIN?
Of the 104 reports, 43 (41.3%) resulted in death, 7 (6.7%) required hospitalization, and 19 (18.3%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IDARUBICIN. However, 104 reports have been filed with the FAERS database.
What Other Side Effects Does IDARUBICIN Cause?
Febrile neutropenia (758)
Off label use (400)
Neutropenia (383)
Pyrexia (313)
Thrombocytopenia (293)
Drug ineffective (291)
Sepsis (289)
Pancytopenia (286)
Pneumonia (239)
Septic shock (227)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which IDARUBICIN Alternatives Have Lower Second primary malignancy Risk?
IDARUBICIN vs IDARUCIZUMAB
IDARUBICIN vs IDECABTAGENE VICLEUCEL
IDARUBICIN vs IDELALISIB
IDARUBICIN vs IDURSULFASE
IDARUBICIN vs IFOSFAMIDE